A variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndrome

Fertility and Sterility

Volumn 94, Issue 7, 2010, Pages 2916-2919

  Raja Khan, Nazia ^a   Kunselman, Allen R ^a   Demers, Laurence M ^a   Ewens, Kathryn G ^b   Spielman, Richard S ^b   Legro, Richard S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

fibrillin; genetic association study; hyperandrogenism; inhibin; insulin resistance; Polycystic ovary syndrome; TGF

Indexed keywords

ALDOSTERONE; FIBRILLIN; FIBRILLIN 3; FOLLISTATIN; INHIBIN B; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INHIBINS; MICROFILAMENT PROTEINS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; YOUNG ADULT;

EID: 78650220962     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.05.047     Document Type: Article

References (27)

1. M. Urbanek, S. Sam, R.S. Legro, and A. Dunaif Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype J Clin Endocrinol Metab 92 2007 4191 4198
2. D.R. Stewart, B.A. Dombroski, M. Urbanek, W. Ankener, K.G. Ewens, and J.R. Wood Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity J Clin Endocrinol Metab 91 2006 4112 4117
3. M. Urbanek, A. Woodroffe, K.G. Ewens, E. Diamanti-Kandarakis, R.S. Legro, and J.F. Strauss 3rd Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2 J Clin Endocrinol Metab 90 2005 6623 6629
4. S. Tucci, W. Futterweit, E.S. Concepcion, D.A. Greenberg, R. Villanueva, and T.F. Davies Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus J Clin Endocrinol Metab 86 2001 446 449
5. V. Kaartinen, and D. Warburton Fibrillin controls TGF-beta activation Nat Genet 33 2003 331 332
6. B.D. Gelb Marfan's syndrome and related disorders - more tightly connected than we thought N Engl J Med 355 2006 841 844
7. D.P. Judge, and H.C. Dietz Marfan's syndrome Lancet 366 2005 1965 1976
8. W.V. Ingman, R.L. Robker, K. Woittiez, and S.A. Robertson Null mutation in transforming growth factor beta1 disrupts ovarian function and causes oocyte incompetence and early embryo arrest Endocrinology 147 2006 835 845
9. C.K. Welt, A.E. Taylor, J. Fox, G.M. Messerlian, J.M. Adams, and A.L. Schneyer Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis J Clin Endocrinol Metab 90 2005 5582 5587
10. R. Fleming, L. Harborne, D.T. MacLaughlin, D. Ling, J. Norman, and N. Sattar Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment Fertil Steril 83 2005 130 136
11. T. Eldar-Geva, I.M. Spitz, N.P. Groome, E.J. Margalioth, and R. Homburg Follistatin and activin A serum concentrations in obese and nonobese patients with polycystic ovary syndrome Hum Reprod 16 2001 2552 2556
12. M. Suthanthiran, B. Li, J.O. Song, R. Ding, V.K. Sharma, and J.E. Schwartz Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage Proc Natl Acad Sci U S A 97 2000 3479 3484
13. E. Diamanti-Kandarakis, F.N. Economou, S. Livadas, E. Tantalaki, C. Piperi, and A.G. Papavassiliou Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy Kidney Blood Press Res 32 2009 24 31
14. T. Cascella, S. Palomba, L. Tauchmanova, F. Manguso, S. di Biase, and D. Labella Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome J Clin Endocrinol Metab 91 2006 4395 4400
15. M.J. Goumans, Z. Liu, and P. ten Dijke TGF-beta signaling in vascular biology and dysfunction Cell Res 19 2009 116 127
16. Rotterdam European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41 47
17. J.K. Zawadski, and A. Dunaif Diagnostic criteria for polycystic ovary syndrome J.H.F. Givens, G. Merriman, The polycystic ovary syndrome 1992 Blackwell Scientific Cambridge, MA 377 384
18. M. Urbanek, R.S. Legro, D.A. Driscoll, R. Azziz, D.A. Ehrmann, and R.J. Norman Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin Proc Natl Acad Sci U S A 96 1999 8573 8578
19. R.S. Legro, D. Driscoll, J.F. Strauss 3rd, J. Fox, and A. Dunaif Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome Proc Natl Acad Sci U S A 95 1998 14956 14960
20. R.S. Legro, A.R. Kunselman, L. Demers, S.C. Wang, R. Bentley-Lewis, and A. Dunaif Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome J Clin Endocrinol Metab 87 2002 2134 2138
21. R. Hatch, R.L. Rosenfield, M.H. Kim, and D. Tredway Hirsutism: implications, etiology, and management Am J Obstet Gynecol 140 1981 815 830
22. A. Dunaif, D. Scott, D. Finegood, B. Quintana, and R. Whitcomb The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome J Clin Endocrinol Metab 81 1996 3299 3306
23. R.S. Legro, R. Bentley-Lewis, D. Driscoll, S.C. Wang, and A. Dunaif Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity J Clin Endocrinol Metab 87 2002 2128 2133
24. C. Demeterco, G.M. Beattie, S.A. Dib, A.D. Lopez, and A. Hayek A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth J Clin Endocrinol Metab 85 2000 3892 3897
25. S. Muttukrishna, D. Tannetta, N. Groome, and I. Sargent Activin and follistatin in female reproduction Mol Cell Endocrinol 225 2004 45 56
26. M. Urbanek, X. Wu, K.R. Vickery, L.C. Kao, L.K. Christenson, and A. Schneyer Allelic variants of the follistatin gene in polycystic ovary syndrome J Clin Endocrinol Metab 85 2000 4455 4461
27. M.J. Prodoehl, N. Hatzirodos, H.F. Irving-Rodgers, Z.Z. Zhao, J.N. Painter, and T.E. Hickey Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries Mol Hum Reprod 15 2009 829 841